Cite
MLA Citation
W W Tan et al.. “N0332 phase 2 trial of weekly irinotecan hydrochloride and docetaxel in refractory metastatic breast cancer: a North Central Cancer Treatment Group (NCCTG) Trial.” Annals of oncology, vol. 29, 2018, p. 2150. http://access.bl.uk/ark:/81055/vdc_100095505017.0x000035